Health Check: The latest ASX biotech IPO is out of the blocks
Nexsen is off and running on its great ASX marathon. Pic: Getty Images Diagnostic play Nexsen surges 47% on its ASX debut, after a well-supported raising Audeara has entered the…
- Fri. Oct 2nd, 2026
Where Innovation Meets Excellence